US Patent 8946416 Process for the synthesis of 5-(methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzeneamine
Patent 8946416 was granted and assigned to Novartis on February, 2015 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8946416 Process for the synthesis of 5-(methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzeneamine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
